Le Centre am\u00e9ricain de contr\u00f4le et de pr\u00e9vention des maladies (CDC) a \u00e9mis un avertissement selon lequel un appareil couramment utilis\u00e9 pour chauffer et refroidir le sang pendant une chirurgie \u00e0 c\u0153ur ouvert peut \u00eatre contamin\u00e9 par une bact\u00e9rie dangereuse, Mycobacterium chimaera. Cette bact\u00e9rie est capable de d\u00e9velopper furtivement un film collant autour d'un c\u0153ur au cours de semaines ou de mois. Ce film collant peut entra\u00eener de multiples complications, y compris la mort. En collaboration avec le CDC et la Food and Drug Administration (FD) des \u00c9tats-Unis, les \u00e9tablissements de chirurgie \u00e0 c\u0153ur ouvert ont contact\u00e9 leurs patients en chirurgie \u00e0 c\u0153ur ouvert pour les informer qu'ils auraient pu \u00eatre expos\u00e9s \u00e0 cette infection bact\u00e9rienne.<\/p>\n
The St\u00f6ckert 3T heater-cooler, manufactured in Germany by LivaNova PLC, was found to be contaminated by the Mycobacterium chimaera bacteria. Despite thorough device cleanings, more cases of infections began popping up across the United States. This prompted officials to suspect that the contamination occurred in the factory during production.<\/p>\n
Anyone who has had open heart surgery since 2011 should consult a medical professional if you are experiencing \u00a0any sign of infection such as fever, fatigue, unintended sweat loss or weight loss. Since the complications associated with M.chimaera could be a long time, it is of the utmost importance to see a doctor if you feel out of the ordinary during recovery. We also encourage you to speak with one of our experienced attorneys to discuss your individual circumstances. The consultation is confidential and free.<\/p>","protected":false},"excerpt":{"rendered":"
The U.S. Center for Disease Control and Prevention (CDC) has issued warning \u00a0that commonly used device for heating and cooling blood during open-heart surgery may be contaminated with a dangerous…<\/p>","protected":false},"featured_media":0,"menu_order":189,"template":"","practiceareas_category":[743],"class_list":["post-5791","practiceareas","type-practiceareas","status-publish","hentry","practiceareas_category-pharmaceutical-litigation"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/practiceareas\/5791","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/practiceareas"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/types\/practiceareas"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/practiceareas\/5791\/revisions"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/media?parent=5791"}],"wp:term":[{"taxonomy":"practiceareas_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/practiceareas_category?post=5791"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}